Bruno Martin A, Cuello A Claudio
Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada H3G 1Y6.
Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6735-40. doi: 10.1073/pnas.0510645103. Epub 2006 Apr 17.
In this report, we provide direct demonstration that the neurotrophin nerve growth factor (NGF) is released in the extracellular space in an activity-dependent manner in its precursor form (proNGF) and that it is in this compartment that its maturation and degradation takes place because of the coordinated release and the action of proenzymes and enzyme regulators. This converting protease cascade and its endogenous regulators (including tissue plasminogen activator, plasminogen, neuroserpin, precursor matrix metalloproteinase 9, and tissue inhibitor metalloproteinase 1) are colocalized in neurons of the cerebral cortex and released upon neuronal stimulation. We also provide evidence that this mechanism operates in in vivo conditions, as the CNS application of inhibitors of converting and degrading enzymes lead to dramatic alterations in the tissue levels of either precursor NGF or mature NGF. Pathological alterations of this cascade in the CNS might cause or contribute to a lack of proper neuronal trophic support in conditions such as cerebral ischemia, seizure and Alzheimer's disease or, conversely, to excessive local production of neurotrophins as reported in inflammatory arthritis pain.
在本报告中,我们提供了直接证据,表明神经营养因子神经生长因子(NGF)以其前体形式(proNGF)以活性依赖的方式释放到细胞外空间,并且正是在这个隔室中,由于酶原和酶调节剂的协同释放及作用,其成熟和降解得以发生。这种转化蛋白酶级联及其内源性调节剂(包括组织纤溶酶原激活物、纤溶酶原、神经丝氨酸蛋白酶、前体基质金属蛋白酶9和金属蛋白酶组织抑制剂1)共定位于大脑皮质的神经元中,并在神经元受到刺激时释放。我们还提供证据表明,这一机制在体内条件下起作用,因为中枢神经系统应用转化酶和降解酶抑制剂会导致前体NGF或成熟NGF的组织水平发生显著变化。中枢神经系统中该级联的病理改变可能在诸如脑缺血、癫痫和阿尔茨海默病等情况下导致或促成神经元营养支持不足,或者相反,如在炎性关节炎疼痛中所报道的那样,导致神经营养因子在局部过度产生。